Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
- Conditions
- AbscessCellulitis
- Interventions
- Device: Type of dressing - AquacelDevice: Type of dressing - Iodoform
- Registration Number
- NCT00984022
- Lead Sponsor
- Valleywise Health
- Brief Summary
This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess.
- Detailed Description
The large increase in the incidence of skin and soft tissue infections cause by methicillin resistant staphylococcus aureus (MRSA) has produced a corresponding increase in the number of ED patients presenting with abscesses that require incision and drainage. This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess. More effective abscess healing will reduce the need for oral antibiotic coverage, which will in turn reduce the potential for drug resistance caused by indiscriminate use of oral antibiotics.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 92
- presenting to Maricopa Medical Center ED with cutaneous abscess requiring incision and drainage
- known sensitivity to Aquacel
- pregnant, nursing, or expecting to become pregnant
- incarcerated patient
- prior treatment of same abscess with incision and drainage
- multiple abscesses
- immunodeficiency
- facial abscess
- suspected osteomyelitis or septic arthritis
- diabetic foot, decubitis, or ischaemic ulcers
- unable to provide informed consent or assent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Aquacel dressing Type of dressing - Aquacel Aquacel dressing for cutaneous abscess Iodoform dressing Type of dressing - Iodoform Iodoform dressing for cutaneous abscess
- Primary Outcome Measures
Name Time Method Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Abscess 2 weeks Participants were assessed to see whether or not the surface area of the abscess was reduced by at least 30%, and the number of such participants is reported.
- Secondary Outcome Measures
Name Time Method Change in Patient Rating of Pain Baseline and 2 weeks Change in mean pain score based on patient self-report, using Wong-Baker FACES pain rating scale. Scale ranges from 0 to 5, where 5 means the worst pain possible and 0 means no pain at all.
Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Cellulitis. 2 weeks Participants were assessed to see whether or not the surface area of the cellulitis was reduced by at least 30% and the number of such participants was reported.
Trial Locations
- Locations (1)
Maricopa Integrated Health System
🇺🇸Phoenix, Arizona, United States